巴柳氮钠治疗未确定型结肠炎(3)
第1页 |
参见附件(315KB,3页)。
参考文献
1 江学良.未确定性结肠炎的诊断与治疗.世界华人消化杂志,2006,14(1):114-115.
2 江学良.溃疡性结肠炎现代诊疗手册.中国医药科技出版社,2006:99-102.
3 中华医学会消化学分会.对炎症性肠病诊断治疗规范的建议.中华消化杂志,2001,21:236-239.
4 郑家驹.炎症性肠病基础与临床科学出版社,2001:39.
5 Friend DR.New oral delivery systems for treatment of inflammatory bowel disease.Adv Drug Deliv Rev,2005,57:247-265.
6 Pardi DS,Smyrk TC,Tremaine WJ,et al.Microscopic colitis:A review.Am J Gastroenterol,2002,97:794-802.
7 江学良.溃疡性结肠炎现代诊疗手册.中国医药科技出版社,2006:120.
8 江学良,崔慧斐.溃疡性结肠炎.中国医药科技出版社,2005:360-361.
9 Christensen LA,Jacobsen BA.5Aminosalicylic acid derivatives.Clinical and pharmaceutical evaluation,1989,35,3-10.
10 Mutlu EA,Farhadi A,Keshavarzian A.New developments in the treatment of inflammatory bowel disease. Expert Opin Investig Drugs,2002,11:365-385.
11 Christensen LA.5Aminosalicylic acid containing drugs.Delivery,fate,and possible clinical implications in man,2000,47:20-41.
12 Sutherland L,Macdonald JK. Oral 5aminosalicylic acid for maintenance of remission in ulcerative. Colitis,2006,19:544.
13 江学良,崔慧斐.溃疡性结肠炎.中国医药科技出版社,2005:366.
14 江学良.溃疡性结肠炎现代诊疗手册.中国医药科技出版社,2006:118-120.
15 Mahmud N,Weir DG,Kelleher D.Systemic levels of free 5aminosalicylic acid depend on the nature of the5aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.
“本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文。”
您现在查看是摘要介绍页,详见PDF附件(315KB,3页)。